Xeris BiopharmaXERS
那斯達克 · USD
6.18
+0.03
(+0.49%)
收盤 06/06 03:59 (UTC+8)
06/06 03:59 (UTC+8)
Xeris BiopharmaXERS
6.18
+0.03
(+0.49%)
財務數據
損益表
- 0.44
- 0.41
- 0.48
- 0.54
- 0.60
- 0.60
- 0.72
- 0.74
- 0.86
- 0.83
- -8.13
- -8.45
- 18.28
- 12.91
- 10.74
- 0.03
- 19.00
- 3.97
- 15.36
- -3.12
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 83,127 | 85,807 | 74,380 | 71,539 | 60,119 | 60,099 | 54,268 | 48,065 | 40,638 | 44,390 |
營業成本 | 10,574 | 10,947 | 10,996 | 11,898 | 8,728 | 9,478 | 13,593 | 7,790 | 5,971 | 7,570 |
營業毛利 | 72,553 | 74,860 | 63,384 | 59,641 | 51,391 | 50,621 | 40,675 | 40,275 | 34,667 | 36,820 |
營業費用 | 64,637 | 58,087 | 56,653 | 55,159 | 54,481 | - | 53,568 | 48,462 | - | 46,661 |
研發費用 | 8,783 | 7,874 | 7,483 | 8,055 | 7,753 | 6,092 | 5,888 | 5,759 | 7,821 | 6,382 |
推銷及管理費用 | 53,144 | 47,502 | 46,459 | 44,393 | 44,018 | 40,139 | 44,969 | 39,993 | 38,380 | 37,568 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 2,710 | 2,711 | 2,711 | 2,711 | 2,710 | 2,711 | 2,711 | 2,710 | 2,711 | 2,711 |
營業利益 | 7,916 | 16,773 | 6,731 | 4,482 | -3,090 | 1,679 | -12,893 | -8,187 | -14,245 | -9,841 |
其他收入及費用 | 1,202 | 1,461 | 1,158 | 948 | 1,175 | 911 | 1,617 | 1,895 | 2,604 | 3,233 |
利息費用 | 6,884 | 7,153 | 7,268 | 7,358 | 7,305 | 7,703 | 7,786 | 7,964 | 7,032 | 7,018 |
稅前純益 | 2,234 | 11,081 | 621 | -1,928 | -9,220 | -5,113 | -19,062 | -14,256 | -18,673 | -13,626 |
所得稅 | - | - | - | - | - | - | -3,324 | 749 | 307 | -236 |
稅後純益 | 2,234 | 11,081 | 621 | -1,928 | -9,220 | -5,113 | -15,738 | -15,005 | -18,980 | -13,390 |
基本每股稅後盈餘(元) | 0.01 | 0.07 | - | -0.01 | -0.06 | -0.03 | -0.11 | -0.10 | -0.14 | - |
稀釋每股稅後盈餘(元) | 0.01 | 0.07 | - | -0.01 | -0.06 | -0.03 | -0.10 | -0.10 | -0.14 | -0.09 |
基本平均股數(千股) | 170523.00 | 165961.00 | 163649.00 | 159459.00 | 152445.00 | 149092.00 | 148993.00 | 148345.00 | 140513.00 | - |
稀釋平均股數(千股) | 177631.00 | 180071.00 | 177617.00 | 159459.00 | 152445.00 | 149092.00 | 148993.00 | 148345.00 | 140513.00 | - |
還原基本每股稅後盈餘(元) | 0.01 | 0.07 | - | -0.01 | -0.06 | -0.03 | -0.11 | -0.10 | -0.14 | - |
還原稀釋每股稅後盈餘(元) | 0.01 | 0.07 | - | -0.01 | -0.06 | -0.03 | -0.10 | -0.10 | -0.14 | -0.09 |
還原基本平均股數(千股) | 170,523 | 165,961 | 163,649 | 159,459 | 152,445 | 149,092 | 148,993 | 148,345 | 140,513 | - |
還原稀釋平均股數(千股) | 177,631 | 180,071 | 177,617 | 159,459 | 152,445 | 149,092 | 148,993 | 148,345 | 140,513 | - |
EBITDA(千元) | 13,217 | 22,297 | 11,921 | 9,414 | 2,072 | 6,474 | -7,541 | -2,629 | -8,038 | -2,968 |